好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adolescent with Unusual Initial Presentation of MOGAD
Autoimmune Neurology
P9 - Poster Session 9 (8:00 AM-9:00 AM)
14-011
NA

A twelve-year-old girl reported an acute transient two-minute headache and stiff neck followed by transient two hour left facial droop, dysarthria, and left extremities paresthesia that prompted negative stroke work up and discharge. Headaches, and intermittent abnormal movements of left hand such as piano playing fingers persisted for three days that evolved in new onset generalized seizures. 
NA
Repeat scan was unremarkable however upon revision previous MRI showed abnormal T2 and FLAIR intense signals in right cerebellum with enhancement. Repeat MRI revealed edema and non-enhancing right brachium pontis suspicious for infiltrating glioma, and later right cortical leptomeningeal enhancement. EEG showed right temporal slowing, and CSF studies were remarkable only for pleocytosis. An extensive oncology work up was unremarkable, and the exam improved except for residual left side numbness, headache, and intermittent low-grade fevers. The infectious workup was unremarkable that prompted discharge on Keppra and Motrin with pending MOG and NMO antibodies. A day later the patient was readmitted for intractable headache, nausea, and vomiting, and started on empirical three-day high dose steroids with full resolution of symptoms and discharge on taper. MOG antibodies came back positive with a 1:80 titer, followed by a five-day course of high dose steroids for recurrent headaches and repeat MOG Ab titer increase to 1:160.
This MOGAD case was challenging for the uncommon presentation for this age with polyfocal cerebral deficits and cerebral cortical encephalitis. Given the clinical phenotype, and a positive MOG antibody test, it fits the international MOGAD Panel proposed criteria. Children aged ten and over have a higher risk of relapse. Since there are no randomized controlled clinical trials on acute or chronic immunotherapy in MOGAD, a decision about prolonged glucocorticoid taper over several months to a year must be made because of the significant risk of relapse upon corticosteroid cessation.
Authors/Disclosures
Emma L. Johnson
PRESENTER 		Ms. Johnson has nothing to disclose.
Antoniya Marinova Doynova, MD Dr. Marinova Doynova has nothing to disclose.
Natalie Moreo, MD Dr. Moreo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PRIME 好色先生, LLC. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apollo Medical Communications. The institution of Dr. Moreo has received research support from InnoCare. The institution of Dr. Moreo has received research support from Novartis .
Sagarika Nallu, MD (University of South Florida) No disclosure on file